Evidence map›Paper›PMID 34574267›Full record

ArticleFoods (Basel, Switzerland)2021

Study of the Lipolysis Effect of Nanoliposome-Encapsulated

Sucheewin Krobthong, Yodying Yingchutrakul, Wonnop Visessanguan, Thanisorn Mahatnirunkul, Pawitrabhorn Samutrtai, Chartchai Chaichana, Phakorn Papan, Kiattawee Choowongkomon

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Unlocking the Potential ofPharmaceutics · 2025
    Review
  4. Ganodermataceae-current status, research, and development in Lower Mekong Basin.Frontiers in cellular and infection microbiology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Sucheewin KrobthongInterdisciplinary Graduate Program in Genetic Engineering, Kasetsart University, Bangkok 10900, Thailand.ORCID 0000-0003-4428-4140
Yodying YingchutrakulNational Omics Center, NSTDA, Pathum Thani 12120, Thailand.
Wonnop VisessanguanNational Center for Genetic Engineering and Biotechnology, NSTDA, Pathum Thani 12120, Thailand.
Thanisorn MahatnirunkulNational Nanotechnology Center, NSTDA, Pathum Thani 12120, Thailand.ORCID 0000-0001-6954-5218
Pawitrabhorn SamutrtaiDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Chartchai ChaichanaSiriraj Center of Research Excellence for Diabetes and Obesity (SiCORE-DO), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Phakorn PapanDepartment of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Kiattawee ChoowongkomonInterdisciplinary Graduate Program in Genetic Engineering, Kasetsart University, Bangkok 10900, Thailand.ORCID 0000-0002-2421-7859
National Science and Technology Development Agency · THChiang Mai University · THKasetsart University · THSiriraj Hospital · TH

Funding

Kasetsart University Research and Development Institute KURDI (FF (KU)25.64)Royal Golden Jubilee (RGJ) Ph.D. Programme NRCT5-RGJ63002-042
6 · The paper itself

Abstract

Excessive lipid accumulation is a serious condition. Therefore, we aimed at developing safe strategies using natural hypolipidemic products. Lingzhi is an edible fungus and potential lipid suppression stimulant. To use Lingzhi as a functional hyperlipidemic ingredient, response surface methodology (RSM) was conducted to optimize the time (X

Indexed as

3T3-L1hypolipidemic activityLingzhipeptidesRSM

Identifiers

PMID34574267
PMCPMC8468392
OpenAlexW3200056586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.